ASH 2016 Page 4 Update on Antibody Therapies in Indolent Non-Hodgkin Lymphoma
Author: cancergrace
Added: 06/28/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 28, 2019 Category: Cancer & Oncology Source Type: podcasts
CLL and Non-Hodgkin Lymphoma, What new drugs are on the horizon and why are they exciting
Author: cancergrace
Added: 06/26/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 27, 2019 Category: Cancer & Oncology Source Type: podcasts
CLL and Non-Hodgkin Lymphoma, What are the risks and benefits of both ibrutinib and Idelalisib
CLL and non-hodgkin lymphoma, What are the risks and benefits of both ibrutinib and Idelalisib
Author: cancergrace
Added: 06/26/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 27, 2019 Category: Cancer & Oncology Source Type: podcasts
Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Should all HL patients be treated the same
Chronic Lymphocytic Leukemia Non-Hodgkin Lymphoma Should all HL patients be treated the same
Author: cancergrace
Added: 06/26/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 27, 2019 Category: Cancer & Oncology Source Type: podcasts
Non-hodgkin lymphoma advances in 2018
Steven Rosen, MD, from the City of Hope, Duarte, CA, discusses the remarkable quantity and quality of information on blood cancer therapeutics that has been collected and presented at the Internationa...
Author: VJHemOnc
Added: 10/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 4, 2018 Category: Cancer & Oncology Source Type: podcasts
Nuances of systemic lymphoma and CNS lymphoma
Speaking from the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2018 meeting, held in Nice, France, Bianca Santomasso, MD, PhD, of Memorial Sloan Kettering Cancer Center, NY, discusses how so...
Author: VJHemOnc
Added: 10/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 4, 2018 Category: Cancer & Oncology Source Type: podcasts
CD47-targeting antibody: targeting the source of non-Hodgkin lymphoma
CD47 has been found to be present on leukemic stem cells, but not on normal hematopoietic stem cells, offering an opportunity to target the source of the disease. Here, Irving Weissman, MD, of the Sta...
Author: VJHemOnc
Added: 10/02/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 2, 2018 Category: Cancer & Oncology Source Type: podcasts
Pathobiology and clinical management of T-cell lymphoma
From the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2018 meeting held in Nice, France, Francine Foss, MD, of Yale University School of Medicine, New Haven, CT, discusses the pathology and...
Author: VJHemOnc
Added: 10/01/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 1, 2018 Category: Cancer & Oncology Source Type: podcasts
Are biomarkers the future in Non-Hodgkin Lymphoma?
Speaking at the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting in Houston, TX, Nathan Fowler, MD, of The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the increasin...
Author: VJHemOnc
Added: 09/19/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 19, 2018 Category: Cancer & Oncology Source Type: podcasts
John P. Leonard, MD - The Arrival of Novel Agent Classes in B-Cell Non-Hodgkin Lymphoma: A Personal Guide to Integrating New Therapy Into Patient Care
The Arrival of Novel Agent Classes in B-Cell Non-Hodgkin Lymphoma: A Personal Guide to Integrating New Therapy Into Patient Care (Source: PeerView CME/CE Audio Podcast - Pulmonology)
Source: PeerView CME/CE Audio Podcast - Pulmonology - July 9, 2018 Category: Respiratory Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Long-term follow-up results of the ZUMA-1 trial of anti-CD19 CAR T-cells for non-Hodgkin lymphoma
The latest CAR T-cell data was highly anticipated at the American Society of Hematology (ASH) 2017 Annual Meeting and Exposition in Atlanta, GA. Speaking from the meeting, Sattva Neelapu, MD, from the...
Author: VJHemOnc
Added: 01/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 5, 2018 Category: Cancer & Oncology Source Type: podcasts
Lymphoma Research and Treatment Update From ASH 2017
Whats the latest news coming out for Hodgkin lymphoma treatment and non-Hodgkin lymphoma treatment? Dr. Andrew Evens at Northwestern Medicine gives us an update from the American Society of Clinical ...
Author: patientpower
Added: 12/21/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 22, 2017 Category: Cancer & Oncology Source Type: podcasts
Making cancer treatments more affordable
Steven T. Rosen, MD, from the City of Hope, Duarte, CA, discusses the affordability of cancer treatments at the 2017 International Workshop in Non-Hodgkin Lymphoma (iwNHL) in Vancouver, BC, Canada. Th...
Author: VJHemOnc
Added: 11/21/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 21, 2017 Category: Cancer & Oncology Source Type: podcasts
Repurposed HIV and arthritis drugs in the treatment of leukaemia
Steven T. Rosen, MD, from the City of Hope, Duarte, CA, discusses novel conceptual treatment approaches at the 2017 International Workshop in Non-Hodgkin Lymphoma (iwNHL) in Vancouver, BC, Canada. A n...
Author: VJHemOnc
Added: 11/21/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 21, 2017 Category: Cancer & Oncology Source Type: podcasts
The evolution of CAR T-cell therapy
Steven T. Rosen, MD, from the City of Hope, Duarte, CA, discusses the evolution of CAR T-cell therapy at the 2017 International Workshop in Non-Hodgkin Lymphoma (iwNHL) in Vancouver, BC, Canada. CAR T...
Author: VJHemOnc
Added: 11/21/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 21, 2017 Category: Cancer & Oncology Source Type: podcasts
